Literature DB >> 32875552

Population-based human papillomavirus infection and genotype distribution among women in rural areas of South Central Ethiopia.

Brhanu Teka1, Muluken Gizaw2,3, Friederike Ruddies3, Adamu Addissie2, Zewditu Chanyalew4, Anna Sophie Skof5, Sarah Thies5, Adane Mihret1,6, Eva Johanna Kantelhardt3,7, Andreas M Kaufmann5, Tamrat Abebe1.   

Abstract

In Ethiopia, cervical cancer is the second leading cause of morbidity and mortality from all cancers in women. Persistent infection with human papillomaviruses (HPV) plays a key role in the development of cervical intraepithelial neoplasia and invasive cervical cancer. To establish baseline data on the population-based prevalence of HPV infection and genotype distribution, we investigated cervical HPV epidemiology among rural women. This population-based study was conducted among rural women aged 30-49 years in Butajira, south-central Ethiopia. A total of 893 samples were tested from 1020 screened women. A self-sampling device (Evalyn Brush, Rovers, Oss, The Netherlands) was used and HPV presence and genotype was determined using multiplexed genotyping (MPG) by BSGP5+/6+ PCR with Luminex read out. The HPV positivity rate was 23.2% (95% CI: 23.54-22.86%) and 20.5% (95% CI = 20.79-20.21) and 10.3% (95% CI = 10.52-10.08) women were high-risk (hr- and low-risk (lr-) HPV positive, respectively. Fifty five (7.2%) of the women showed multiple hr-HPV infections. Age-specific hr-HPV infection peaked in the age-group 30- to 34 years old (58.6%) and decreased in 35-39, 40-44 and 45-49 years to 20.4%, 4.5% and 3.8% respectively. The top five prevalent hr-HPV genotypes were HPV16 (57.1%), 35 (20.3%), 52 (15.8%), 31 (14.1%), and 45 (9.6%) in the Butajira district. As a first population-based study in the country, our results can serve as valuable reference to guide nationwide cervical cancer screening and HPV vaccination programs in Ethiopia.
© 2020 Union for International Cancer Control.

Entities:  

Keywords:  Butajira; HPV based screening; HPV epidemiology; cervical cancer; high-risk HPV

Mesh:

Substances:

Year:  2020        PMID: 32875552     DOI: 10.1002/ijc.33278

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

Review 1.  Cervical cancer in Ethiopia: a review of the literature.

Authors:  Awoke Derbie; Daniel Mekonnen; Endalkachew Nibret; Eyaya Misgan; Melanie Maier; Yimtubezinash Woldeamanuel; Tamrat Abebe
Journal:  Cancer Causes Control       Date:  2022-10-15       Impact factor: 2.532

2.  Knowledge, Attitude, and Practice Toward Cervical Cancer Screening Among Women Attending Health Facilities in Central Ethiopia.

Authors:  Tulu Gebisa; Elias Teferi Bala; Berhanu Senbeta Deriba
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

3.  A Technical Comparison of Human Papillomavirus Genotyping Assays from a Population-Based Cervical Cancer Screening in South Central Ethiopia.

Authors:  Brhanu Teka; Muluken Gizaw; Ededia Firdawoke; Adamu Addissie; Tesfamichael Awoke Sisay; Carola Schreckenberger; Anna Sophie Skof; Sarah Thies; Adane Mihret; Eva Johanna Kantelhardt; Tamrat Abebe; Andreas M Kaufmann
Journal:  Cancer Manag Res       Date:  2022-07-29       Impact factor: 3.602

Review 4.  Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection Among Sub-Saharan African Women: A Systematic Review and Meta-Analysis.

Authors:  Ayichew Seyoum; Nega Assefa; Tadesse Gure; Berhanu Seyoum; Andargachew Mulu; Adane Mihret
Journal:  Front Public Health       Date:  2022-07-08

5.  Prevalence and Determinants of Pre-Cancerous Cervical Lesion and Human Papillomavirus Among HIV-Infected and HIV-Uninfected Women in North-West Ethiopia: A Comparative Retrospective Cross-Sectional Study.

Authors:  Mulugeta Kiros; Demeke Mesfin Belay; Sisay Getu; Wasihun Hailemichael; Ahmed Esmael; Henok Andualem; Alene Geteneh
Journal:  HIV AIDS (Auckl)       Date:  2021-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.